Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Synthesis and in vitro anti-HIV evaluation of a new series of 6-arylmethyl-substituted S-DABOs as potential non-nucleoside HIV-1 reverse transcriptase inhibitors.

Identifieur interne : 001D12 ( Ncbi/Curation ); précédent : 001D11; suivant : 001D13

Synthesis and in vitro anti-HIV evaluation of a new series of 6-arylmethyl-substituted S-DABOs as potential non-nucleoside HIV-1 reverse transcriptase inhibitors.

Auteurs : Yue-Ping Wang [République populaire de Chine] ; Fen-Er Chen ; Erik De Clercq ; Jan Balzarini ; Christophe Pannecouque

Source :

RBID : pubmed:18692274

Descripteurs français

English descriptors

Abstract

A series of new 5-alkyl-2-benzylsulfanylpyrimidin-4(3H)-ones (5a-y) bearing different substituted arylmethyl moieties at the C-6 position of the pyrimidine core have been synthesized and evaluated for their in vitro activities against HIV-1 and HIV-2 in MT-4 cell cultures. The majority of the title compounds showed moderate to good activities against HIV-1 with an IC(50) range from 6.67 microM to 0.12 microM. Among them, 6-(3,5-dimethylbenzyl) analogue 5q exhibited the most potent anti-HIV-1 activity (IC(50)=0.12 microM, SI>2642), which was about 40-fold more active than the reference compounds 1-[(2-hydroxyethoxy)methyl]-6-(phenylsulfanyl)thymine (HEPT) and 2',3'-dideoxyinosine (DDI). The structure-activity relationships (SARs) of these new congeners were further discussed.

DOI: 10.1016/j.ejmech.2008.06.028
PubMed: 18692274

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:18692274

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Synthesis and in vitro anti-HIV evaluation of a new series of 6-arylmethyl-substituted S-DABOs as potential non-nucleoside HIV-1 reverse transcriptase inhibitors.</title>
<author>
<name sortKey="Wang, Yue Ping" sort="Wang, Yue Ping" uniqKey="Wang Y" first="Yue-Ping" last="Wang">Yue-Ping Wang</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Chemistry, Fudan University, Shanghai 200433, PR China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Chemistry, Fudan University, Shanghai 200433</wicri:regionArea>
<wicri:noRegion>Shanghai 200433</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Chen, Fen Er" sort="Chen, Fen Er" uniqKey="Chen F" first="Fen-Er" last="Chen">Fen-Er Chen</name>
</author>
<author>
<name sortKey="De Clercq, Erik" sort="De Clercq, Erik" uniqKey="De Clercq E" first="Erik" last="De Clercq">Erik De Clercq</name>
</author>
<author>
<name sortKey="Balzarini, Jan" sort="Balzarini, Jan" uniqKey="Balzarini J" first="Jan" last="Balzarini">Jan Balzarini</name>
</author>
<author>
<name sortKey="Pannecouque, Christophe" sort="Pannecouque, Christophe" uniqKey="Pannecouque C" first="Christophe" last="Pannecouque">Christophe Pannecouque</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2009">2009</date>
<idno type="RBID">pubmed:18692274</idno>
<idno type="pmid">18692274</idno>
<idno type="doi">10.1016/j.ejmech.2008.06.028</idno>
<idno type="wicri:Area/PubMed/Corpus">001A90</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001A90</idno>
<idno type="wicri:Area/PubMed/Curation">001A90</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001A90</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001770</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001770</idno>
<idno type="wicri:Area/Ncbi/Merge">001D12</idno>
<idno type="wicri:Area/Ncbi/Curation">001D12</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Synthesis and in vitro anti-HIV evaluation of a new series of 6-arylmethyl-substituted S-DABOs as potential non-nucleoside HIV-1 reverse transcriptase inhibitors.</title>
<author>
<name sortKey="Wang, Yue Ping" sort="Wang, Yue Ping" uniqKey="Wang Y" first="Yue-Ping" last="Wang">Yue-Ping Wang</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Chemistry, Fudan University, Shanghai 200433, PR China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Chemistry, Fudan University, Shanghai 200433</wicri:regionArea>
<wicri:noRegion>Shanghai 200433</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Chen, Fen Er" sort="Chen, Fen Er" uniqKey="Chen F" first="Fen-Er" last="Chen">Fen-Er Chen</name>
</author>
<author>
<name sortKey="De Clercq, Erik" sort="De Clercq, Erik" uniqKey="De Clercq E" first="Erik" last="De Clercq">Erik De Clercq</name>
</author>
<author>
<name sortKey="Balzarini, Jan" sort="Balzarini, Jan" uniqKey="Balzarini J" first="Jan" last="Balzarini">Jan Balzarini</name>
</author>
<author>
<name sortKey="Pannecouque, Christophe" sort="Pannecouque, Christophe" uniqKey="Pannecouque C" first="Christophe" last="Pannecouque">Christophe Pannecouque</name>
</author>
</analytic>
<series>
<title level="j">European journal of medicinal chemistry</title>
<idno type="eISSN">1768-3254</idno>
<imprint>
<date when="2009" type="published">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Cell Line</term>
<term>Crystallography, X-Ray</term>
<term>HIV Reverse Transcriptase (antagonists & inhibitors)</term>
<term>HIV-1 (drug effects)</term>
<term>Humans</term>
<term>Magnetic Resonance Spectroscopy</term>
<term>Pyrimidinones (chemical synthesis)</term>
<term>Pyrimidinones (chemistry)</term>
<term>Pyrimidinones (pharmacology)</term>
<term>Reverse Transcriptase Inhibitors (chemical synthesis)</term>
<term>Reverse Transcriptase Inhibitors (chemistry)</term>
<term>Reverse Transcriptase Inhibitors (pharmacology)</term>
<term>Spectrometry, Mass, Electrospray Ionization</term>
<term>Spectroscopy, Fourier Transform Infrared</term>
<term>Structure-Activity Relationship</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Cristallographie aux rayons X</term>
<term>Humains</term>
<term>Inhibiteurs de la transcriptase inverse ()</term>
<term>Inhibiteurs de la transcriptase inverse (pharmacologie)</term>
<term>Inhibiteurs de la transcriptase inverse (synthèse chimique)</term>
<term>Lignée cellulaire</term>
<term>Pyrimidinones ()</term>
<term>Pyrimidinones (pharmacologie)</term>
<term>Pyrimidinones (synthèse chimique)</term>
<term>Relation structure-activité</term>
<term>Spectrométrie de masse ESI</term>
<term>Spectroscopie infrarouge à transformée de Fourier</term>
<term>Spectroscopie par résonance magnétique</term>
<term>Transcriptase inverse du VIH (antagonistes et inhibiteurs)</term>
<term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1) ()</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en">
<term>HIV Reverse Transcriptase</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemical synthesis" xml:lang="en">
<term>Pyrimidinones</term>
<term>Reverse Transcriptase Inhibitors</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en">
<term>Pyrimidinones</term>
<term>Reverse Transcriptase Inhibitors</term>
</keywords>
<keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr">
<term>Transcriptase inverse du VIH</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>HIV-1</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Inhibiteurs de la transcriptase inverse</term>
<term>Pyrimidinones</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Pyrimidinones</term>
<term>Reverse Transcriptase Inhibitors</term>
</keywords>
<keywords scheme="MESH" qualifier="synthèse chimique" xml:lang="fr">
<term>Inhibiteurs de la transcriptase inverse</term>
<term>Pyrimidinones</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Cell Line</term>
<term>Crystallography, X-Ray</term>
<term>Humans</term>
<term>Magnetic Resonance Spectroscopy</term>
<term>Spectrometry, Mass, Electrospray Ionization</term>
<term>Spectroscopy, Fourier Transform Infrared</term>
<term>Structure-Activity Relationship</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Cristallographie aux rayons X</term>
<term>Humains</term>
<term>Inhibiteurs de la transcriptase inverse</term>
<term>Lignée cellulaire</term>
<term>Pyrimidinones</term>
<term>Relation structure-activité</term>
<term>Spectrométrie de masse ESI</term>
<term>Spectroscopie infrarouge à transformée de Fourier</term>
<term>Spectroscopie par résonance magnétique</term>
<term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1)</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">A series of new 5-alkyl-2-benzylsulfanylpyrimidin-4(3H)-ones (5a-y) bearing different substituted arylmethyl moieties at the C-6 position of the pyrimidine core have been synthesized and evaluated for their in vitro activities against HIV-1 and HIV-2 in MT-4 cell cultures. The majority of the title compounds showed moderate to good activities against HIV-1 with an IC(50) range from 6.67 microM to 0.12 microM. Among them, 6-(3,5-dimethylbenzyl) analogue 5q exhibited the most potent anti-HIV-1 activity (IC(50)=0.12 microM, SI>2642), which was about 40-fold more active than the reference compounds 1-[(2-hydroxyethoxy)methyl]-6-(phenylsulfanyl)thymine (HEPT) and 2',3'-dideoxyinosine (DDI). The structure-activity relationships (SARs) of these new congeners were further discussed.</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001D12 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 001D12 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:18692274
   |texte=   Synthesis and in vitro anti-HIV evaluation of a new series of 6-arylmethyl-substituted S-DABOs as potential non-nucleoside HIV-1 reverse transcriptase inhibitors.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i   -Sk "pubmed:18692274" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021